+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Arthrex Inc - Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 41 Pages
  • May 2026
  • GlobalData
  • Arthrex, Inc.
  • ID: 1936205
Arthrex Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Report Scope

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - The analyst’s summarization of the company’s business strategy.
  • SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.

Highlights

Arthrex Inc (Arthrex) designs and manufactures surgical products and solutions used for arthroscopic and minimally invasive orthopedic surgical procedures. The company offers shoulder, knee, elbow, hand and wrist, foot and ankle, and hip related surgical products, orthobiologics and imaging and resection systems. It also provides medical education; training programs; physician observation program; surgical outcomes system orthopedic and sports medicine global registry; and patient education. The company markets products directly and through a network of distributors in the Americas, Europe, the Middle East, Africa and Asia. Arthrex is headquartered in Naples, Florida, the US.

Arthrex Inc Key Recent Developments

  • May 08, 2026: ACL Repair Helps Active Patient Recover Within Weeks
  • Apr 15, 2026: Inside Medicine Magazine Highlights Arthrex Endoscopic Spine Technology and Ultra-Minimally Invasive Surgery
  • Mar 20, 2026: Two Arthrex Technologies Named Finalists for 2026 Edison Awards
  • Feb 26, 2026: Arthrex Releases TightRope SB All-Suture Implant for ACL Fixation

Reasons to Buy

  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with the analyst’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.

Table of Contents

Section 1 - About the Company
  • Arthrex Inc - Key Facts
  • Arthrex Inc - Key Employees
  • Arthrex Inc - Major Products and Services
  • Arthrex Inc - History
  • Arthrex Inc - Company Statement
  • Arthrex Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Arthrex Inc - Business Description
  • Arthrex Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Arthrex Inc - Strengths
  • Arthrex Inc - Weaknesses
  • Arthrex Inc - Opportunities
  • Arthrex Inc - Threats
  • Arthrex Inc - Key Competitors
Section 3 - Company’s Lifesciences Financial Deals and Alliances
  • Arthrex Inc, Medical Equipment, Deals By Year, 2020 to YTD 2026
  • Arthrex Inc, Medical Equipment, Deals By Type, 2020 to YTD 2026
  • Arthrex Inc, Recent Deals Summary
Section 4 - Company’s Recent Developments
  • May 08, 2026: ACL Repair Helps Active Patient Recover Within Weeks
  • Apr 15, 2026: Inside Medicine Magazine Highlights Arthrex Endoscopic Spine Technology and Ultra-Minimally Invasive Surgery
  • Mar 20, 2026: Two Arthrex Technologies Named Finalists for 2026 Edison Awards
  • Feb 26, 2026: Arthrex Releases TightRope SB All-Suture Implant for ACL Fixation
  • Feb 02, 2026: Atlantic Brain & Spine Surgeon Completes 50th Ultra-Minimally Invasive Procedure With Arthrex Endoscopic Spine System
  • Dec 10, 2025: Arthrex Endoscopic Spine Technology Featured on NOLA Now
  • Nov 24, 2025: Arthrex ACL Innovation Featured on Tampa Bay ABC Affiliate
  • Sep 23, 2025: Arthrex Completes First Case With NanoNeedle Scope 2.0
  • Sep 15, 2025: Reinhold Schmieding Interviewed for ASES Podcast
  • Sep 05, 2025: STARability Foundation Honors Arthrex with STAR Award
Section 5 - Appendix
  • Methodology
  • About the Analyst
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Arthrex Inc, Key Facts
  • Arthrex Inc, Key Employees
  • Arthrex Inc, Major Products and Services
  • Arthrex Inc, History
  • Arthrex Inc, Subsidiaries
  • Arthrex Inc, Key Competitors
  • Arthrex Inc, Medical Equipment, Deals By Year, 2020 to YTD 2026
  • Arthrex Inc, Medical Equipment, Deals By Type, 2020 to YTD 2026
  • Arthrex Inc, Recent Deals Summary
List of Figures
  • Arthrex Inc, Medical Equipment, Deals By Year, 2020 to YTD 2026
  • Arthrex Inc, Medical Equipment, Deals by Type, 2020 to YTD 2026

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Smith & Nephew Plc
  • CONMED Corp
  • AlloSource
  • Stryker Corp
  • Globus Medical Inc